Prevalence and conditions of selection of the K65R mutation in the reverse transcriptase gene of HIV-1

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):110-1. doi: 10.1097/00126334-200501010-00019.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Amino Acid Substitution
  • Anti-HIV Agents / therapeutic use
  • Drug Resistance, Viral / genetics
  • Gene Frequency
  • Genes, Viral*
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / drug effects
  • HIV-1 / enzymology*
  • HIV-1 / genetics*
  • Humans
  • Organophosphonates / therapeutic use
  • Point Mutation*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Selection, Genetic
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Tenofovir
  • HIV Reverse Transcriptase
  • Adenine